In assessing for fecal transplant to newborns, more than 40% of enrolled mothers tested positive for potentially harmful pathogens.
Approval of Rebyota, made by Ferring Pharmaceuticals, was based on findings from multiple randomized clinical trials.
The alert comes after 6 patients were infected with diarrhea-causing E coli following FMT.
The FDA recommends screening donor stool for multidrug-resistant organisms. Problem is, the procedures aren't uniform.
One patient is dead and one ill after contracting drug-resistant E coli after FMT.
A new study in the Journal of Drugs and Dermatology suggests that a diuretic drug may be as effective as antibiotics for treatment of women's acne.
A retrospective analysis of antibiotic prescriptions in England published yesterday in the Journal of Antimicrobial Chemotherapy found that nearly 8% of all antibiotics dispensed in primary care are prescribed by non-medical prescribers (NMPs), mostly nurses.
Biotechnology firm Seres Therapeutics announced late last week that SER-109, a drug designed to treat patients with recurring Clostridium difficile infections (CDIs), failed in a phase 2 study.
A nationwide campaign to isolate 100% of Ebola cases and conduct all burial safely, alongside a global response plan, was a key intervention that helped curb transmission in Sierra Leone, according to a study of illness patterns in chiefdoms and households.
A federal vaccine advisory group yesterday recommended that adults age 65 and older receive the Prevnar 13 pneumococcal conjugate vaccine, according to a press release from Pfizer Inc., the vaccine's maker. Using the vaccine alongside the current 23-valent pneumococcal vaccine is thought to provide broader protection.
